These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20074496)

  • 1. Anemia and chronic kidney disease: what's the connection?
    Taliercio JJ
    J Fam Pract; 2010 Jan; 59(1):14-8. PubMed ID: 20074496
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence of anemia in patients with chronic kidney disease.
    McClellan W; Aronoff SL; Bolton WK; Hood S; Lorber DL; Tang KL; Tse TF; Wasserman B; Leiserowitz M
    Curr Med Res Opin; 2004 Sep; 20(9):1501-10. PubMed ID: 15383200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients.
    Rossert J; Gassmann-Mayer C; Frei D; McClellan W
    Nephrol Dial Transplant; 2007 Mar; 22(3):794-800. PubMed ID: 17210593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anemia of chronic kidney failure].
    Vernant JP
    Rev Prat; 1978 Dec; 28(55):4405-10. PubMed ID: 749163
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of renal anemia in progression of chronic kidney disease].
    Racki S; Maleta I
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():33-7. PubMed ID: 20235353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin variability in dialysis patients.
    Brimble KS; Clase CM
    J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931
    [No Abstract]   [Full Text] [Related]  

  • 7. Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review.
    Germain M; Ram CV; Bhaduri S; Tang KL; Klausner M; Curzi M
    Nephrol Dial Transplant; 2005 Oct; 20(10):2146-52. PubMed ID: 15985516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemoglobin target for chronic kidney disease patients?].
    Drüeke TB
    Nephrol Ther; 2007 Oct; 3(6):369-71. PubMed ID: 17919639
    [No Abstract]   [Full Text] [Related]  

  • 9. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure.
    de Silva R; Rigby AS; Witte KK; Nikitin NP; Tin L; Goode K; Bhandari S; Clark AL; Cleland JG
    Am J Cardiol; 2006 Aug; 98(3):391-8. PubMed ID: 16860030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR.
    Levin A
    Nephrol Dial Transplant; 2007 Feb; 22(2):309-12. PubMed ID: 17234670
    [No Abstract]   [Full Text] [Related]  

  • 11. Anemia in renal insufficiency.
    Santoro A
    Rev Clin Exp Hematol; 2002; Suppl 1():12-20. PubMed ID: 12735211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality of life assessment in a recent haemoglobin trial in CKD (CHOIR).
    Kutner N
    Nephrol Dial Transplant; 2007 Jul; 22(7):2099. PubMed ID: 17395656
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anemia in diabetic nephropathy: prevalence, clinical and pathophysiological aspects].
    Shestakova MV; Martynov SA; Il'in AV; Kniazeva AP; Shamkhalova MSh; Trubitsyna NP
    Ter Arkh; 2008; 80(6):41-7. PubMed ID: 18655475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia in CKD: prevalence, diagnosis, and treatment. Case study of the anemic patient.
    Kammerer J; Ratican M; Elzein H; Mapes D
    Nephrol Nurs J; 2002 Aug; 29(4):371-4. PubMed ID: 12224371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of anemia in the nursing home: contribution of chronic kidney disease.
    Robinson B; Artz AS; Culleton B; Critchlow C; Sciarra A; Audhya P
    J Am Geriatr Soc; 2007 Oct; 55(10):1566-70. PubMed ID: 17727646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating anemia with erythropoiesis-stimulating agents: effects on quality of life.
    Moossavi S; Freedman BI
    Arch Intern Med; 2009 Jun; 169(12):1100-1. PubMed ID: 19546408
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemoglobin levels, cardiovascular disease, and left ventricular hypertrophy in patients with chronic kidney disease. Case study of the anemic patient.
    Butler KG
    Nephrol Nurs J; 2002 Apr; 29(2):189-92. PubMed ID: 11997954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point?
    Covic A; Seica A; Gusbeth-Tatomir P; Goldsmith D
    J Nephrol; 2008; 21(4):478-84. PubMed ID: 18651536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.